Journal of the American Heart Association · 2025
Blood Pressure Variability as a Diagnostic Marker for α-Synucleinopathy in Patients With Orthostasis.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Woo Tonghoon, Kim Jueun, Kim Keun-Tae, Baik Kyoungwon, Park Jin-Woo, Lee Sun-Uk, Park Euyhyun, Lee Chan-Nyoung, Kim Byung-Jo, Kim Ji-Soo
Аннотация
BACKGROUND: It is widely accepted that patients with α-synucleinopathy show large blood pressure (BP) variability. We aimed to investigate the diagnostic utility of ambulatory BP monitoring in detecting α-synucleinopathy in patients with orthostasis.
METHODS: We prospectively recruited consecutive patients with orthostatic dizziness between December 2021 and February 2024 at the Dizziness Center of a tertiary referral-based hospital in South Korea. All patients underwent a detailed examination using Frenzel goggles and systematic extrapyramidal neurologic examination for eligibility. All patients underwent 24-hour noninvasive ambulatory BP monitoring and head-up tilt table test using a Finometer.
RESULTS: Among the 223 patients, 22 (10%) were finally diagnosed with α-synucleinopathy. The diagnosis could have been made with emergence of motor symptoms 1 to 3 years after the presentation in 5 (22%) of the 22 patients. The coefficient of variance of systolic BP (SBP; P=0.023) and differences in the average systolic BP between day and night (P=0.001) were associated with α-synucleinopathy, after adjusting for other covariates. Differences in the average systolic BP between day and night yielded a sensitivity of 76.2% and specificity of 83.6% in discriminating α-synucleinopathy, with an area under the curve of 0.79 (95% CI, 0.66-0.92). The sensitivity and specificity were 77.3% and 71.6% with an area under the curve of 0.80 (95% CI, 0.70-0.90) for the coefficient of variance of systolic BP.
CONCLUSIONS: Our findings implicate that ambulatory BP monitoring can help detect α-synucleinopathy in patients with orthostasis. Large BP variability and loss of circadian BP rhythm during ambulatory BP monitoring can serve as early warning signs of α-synucleinopathy, even before the prominent manifestation of motor symptoms.
METHODS: We prospectively recruited consecutive patients with orthostatic dizziness between December 2021 and February 2024 at the Dizziness Center of a tertiary referral-based hospital in South Korea. All patients underwent a detailed examination using Frenzel goggles and systematic extrapyramidal neurologic examination for eligibility. All patients underwent 24-hour noninvasive ambulatory BP monitoring and head-up tilt table test using a Finometer.
RESULTS: Among the 223 patients, 22 (10%) were finally diagnosed with α-synucleinopathy. The diagnosis could have been made with emergence of motor symptoms 1 to 3 years after the presentation in 5 (22%) of the 22 patients. The coefficient of variance of systolic BP (SBP; P=0.023) and differences in the average systolic BP between day and night (P=0.001) were associated with α-synucleinopathy, after adjusting for other covariates. Differences in the average systolic BP between day and night yielded a sensitivity of 76.2% and specificity of 83.6% in discriminating α-synucleinopathy, with an area under the curve of 0.79 (95% CI, 0.66-0.92). The sensitivity and specificity were 77.3% and 71.6% with an area under the curve of 0.80 (95% CI, 0.70-0.90) for the coefficient of variance of systolic BP.
CONCLUSIONS: Our findings implicate that ambulatory BP monitoring can help detect α-synucleinopathy in patients with orthostasis. Large BP variability and loss of circadian BP rhythm during ambulatory BP monitoring can serve as early warning signs of α-synucleinopathy, even before the prominent manifestation of motor symptoms.